Vext Science Inc Market Cap ($31.28 Million)
Market Cap & Net Worth: Vext Science Inc (VV5)
Vext Science Inc market cap. Vext Science Inc (F:VV5) has a market capitalization of $31.28 Million (€26.75 Million) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #23426 globally and #2048 in its home market, demonstrating a -5.26% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vext Science Inc's stock price €0.14 by its total outstanding shares 185793173 (185.79 Million). Also see Vext Science Inc cash conversion from operations for how efficiently the company converts equity into cash flow.
Vext Science Inc Market Cap History (2019–2026)
Vext Science Inc market cap history from 2019 to 2026. Data shows change from $102.52 Million to $31.28 Million (-24.89% CAGR). Check Vext Science Inc stock price for real-time trading data and today's change.
Vext Science Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vext Science Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Vext Science Inc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.62x
Vext Science Inc's market cap is 0.62 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $102.52 Million | $22.32 Million | $2.79 Million | 4.59x | 36.70x |
| 2020 | $135.76 Million | $25.19 Million | $2.13 Million | 5.39x | 63.88x |
| 2021 | $94.70 Million | $37.24 Million | $4.99 Million | 2.54x | 18.99x |
| 2022 | $36.71 Million | $35.41 Million | $10.92 Million | 1.04x | 3.36x |
| 2023 | $40.40 Million | $34.81 Million | $4.40 Million | 1.16x | 9.19x |
| 2024 | $22.16 Million | $36.00 Million | -$22.44 Million | 0.62x | N/A |
Competitor Companies of VV5 by Market Capitalization
Companies near Vext Science Inc in the global market cap rankings as of November 3, 2026. Also see VV5 total assets for a full breakdown of the balance sheet.
Key companies related to Vext Science Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #516 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #591 globally with a market cap of $45.45 Billion USD ( CN¥310.59 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #516 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.55 |
| #591 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.45 Billion | CN¥48.69 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Vext Science Inc (2019–2026)
Market capitalization of Vext Science Inc from 2019 to today. Between 2019 and today, Vext Science Inc's market cap moved from $102.52 Million to $ 31.28 Million, with a yearly change of -24.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €31.28 Million | -8.28% |
| 2025 | €34.10 Million | +53.92% |
| 2024 | €22.16 Million | -45.16% |
| 2023 | €40.40 Million | +10.06% |
| 2022 | €36.71 Million | -61.24% |
| 2021 | €94.70 Million | -30.24% |
| 2020 | €135.76 Million | +32.42% |
| 2019 | €102.52 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Vext Science Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $31.28 Million USD |
| MoneyControl | $31.28 Million USD |
| MarketWatch | $31.28 Million USD |
| marketcap.company | $31.28 Million USD |
| Reuters | $31.28 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vext Science Inc
Vext Science, Inc., through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. The company al… Read more